SAVANNAH,
Ga.–(BUSINESS WIRE)–Health Discovery
Corporation, the molecular diagnostics company that launched
MelApp, the first SVM-based image analysis iPhone app for melanoma risk
assessment, today debuts its popular MelApp mobile app for Android™ devices.
Now, health-conscious consumers can easily learn about melanoma and identify
areas on their skin which may need attention from a specialist, anytime,
anywhere with their iPhone, iPod Touch and iPad, as well as Android smartphone.
First launched this summer for iPhone, MelApp uses highly
sophisticated patent protected mathematical algorithms and image based pattern
recognition technology to analyze an uploaded image. The app was validated
using an image database licensed from Johns Hopkins
University Medical
Center and uses a
devices camera feature to deliver a risk analysis of users photographed skin
lesions within seconds. In addition, MelApp can use the smartphones GPS to
refer users to physicians specializing in the diagnosis and treatment of
melanoma for proper medical diagnosis and treatment.
“Being currently used in nearly 50 countries, and having
been named one of the ‘Top 10 Apps That Could Save Your Life in a recent issue
of Parade Magazine, MelApp has become a worldwide success,” stated Stephen D.
Barnhill, M.D. Chairman and CEO of Health Discovery Corporation. “With the launch
of MelApp for Android our goal was to extend the availability of this easy to
use, inexpensive and potentially life-saving app to the more than 46 percent of
the smart phone market that use Android devices, according to Nielsen.”
Now available for iPhone, iPod touch, and iPad, as well as
for Android, MelApp is available for download at a special limited time price
of $1.99 at the following app marketplaces:
- iTunes App Store – http://itunes.apple.com/us/app/melapp/id446669257?mt=8&ls=1
- Android Marketplace – https://market.android.com/search?q=MelApp&c=apps
This version of MelApp for Android has been optimized for
the Droid X. For support and technical inquiries, contact support@healthdiscoverylabs.com.
Physicians who diagnose and treat melanoma can become a
subscribing member of HDCs physician referral network by contacting melappreferral@healthdiscoverycorp.com.
About MelApp & Health Discovery Corporation
MelApp uses highly sophisticated patent protected mathematical algorithms and
image based pattern recognition technology to analyze the uploaded image.
MelApp was validated using an image database licensed from Johns Hopkins
University Medical
Center and uses a
devices camera feature to deliver a risk analysis of users photographed skin
lesions within seconds. The app can use the iPhone GPS to refer users to
physicians specializing in the diagnosis and treatment of melanoma for proper
medical follow-up. MelApp by Health Discovery Corporation is available at a
special limited time introductory price of $1.99. For more complete details,
visit http://www.melapp.net, http://www.facebook.com/MelApp or http://twitter.com/#!/SafeHealthApps.
Health Discovery Corporation is a molecular diagnostics
company that uses advanced mathematical techniques to analyze large amounts of
data to uncover patterns that might otherwise be undetectable. It operates
primarily in the emerging field of personalized medicine where such tools are
critical to scientific discovery. Its primary business consists of licensing
its intellectual property and developing its own product line of
biomarker-based diagnostic tests that include human genes and genetic
variations, as well as gene, protein, and metabolic expression differences and
image analysis in digital pathology and radiology. For more information, see www.healthdiscoverycorp.com.
Posted by Sean Fenske, Editor-in-Chief, MDT
